Geoff Martha, executive vice president of the company's
restorative therapies group, will succeed Ishrak, the company
said in a statement.
Martha joined Medtronic in 2011 and led the integration of
Covidien into Medtronic as part of its $42.9 billion deal for
the surgical devices maker in 2014.
Under him, Medtronic's restorative therapies group generated
revenue of more than $8 billion for the device maker in 2019.
Ishrak, who will turn 65 next year, will continue to be the
chairman of board, the company said.
Before joining Medtronic as CEO in 2011, Ishrak spent 16 years
at General Electric Company.
(Reporting by Manas Mishra and Manojna Maddipatla in Bengaluru;
Editing by Anil D'Silva and Arun Koyyur)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|